X-ray enabled detection and eradication of circulating tumor cells with nanoparticles

Biosens Bioelectron. 2012 Oct-Dec;38(1):348-54. doi: 10.1016/j.bios.2012.06.020. Epub 2012 Jun 23.

Abstract

The early detection and eradication of circulating tumor cells (CTCs) play an important role in cancer metastasis management. This paper describes a new nanoparticle-enabled technique for integrated enrichment, detection and killing of CTCs by using magnetic nanoparticles and bismuth nanoparticles, X-ray fluorescence spectrometry, and X-ray radiation. The nanoparticles are modified with tumor targeting agents and conjugated with tumor cells through folate receptors over-expressed on cancer cells. A permanent micro-magnet is used to collect CTCs suspended inside a flowing medium that contains phosphate buffered saline (PBS) or whole blood. The characteristic X-ray emissions from collected bismuth nanoparticles, upon excitation with collimated X-rays, are used to detect CTCs. Results show that the method is capable of selectively detecting CTCs at concentrations ranging from 100-100,000 cells/mL in the buffer solution, with a detection limit of ≈ 100 CTCs/mL. Moreover, the dose of primary X-rays can be enhanced to kill the localized CTCs by radiation induced DNA damage, with minimal invasiveness, thus making in vivo personalized CTC management possible.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Bismuth / chemistry
  • Bismuth / therapeutic use
  • Cell Death / radiation effects
  • Cell Line, Tumor
  • Humans
  • Magnetite Nanoparticles / chemistry
  • Magnetite Nanoparticles / therapeutic use
  • Magnetite Nanoparticles / ultrastructure
  • Nanoparticles / chemistry*
  • Nanoparticles / therapeutic use*
  • Nanoparticles / ultrastructure
  • Neoplasms / radiotherapy*
  • Neoplastic Cells, Circulating / pathology
  • Neoplastic Cells, Circulating / radiation effects*
  • X-Ray Therapy

Substances

  • Magnetite Nanoparticles
  • Bismuth